Glenmark Life Sciences IPO HNI Funding Cost Calculator

Glenmark Life Sciences IPO Details

Issue Open Jul 27, 2021
Issue Close Jul 29, 2021
IPO Price ₹720
Face Value ₹2
IPO Size ₹1,513.60 Cr
Listing At BSE, NSE
IPO Lot Size 20

Glenmark Life Sciences IPO Subscription Status (Bidding Detail)

The Glenmark Life Sciences IPO is subscribed 44.17 times on Jul 29, 2021 17:01. The public issue subscribed 14.63 in the retail category, 36.97 in the QIB category, and 122.54 in the NII category. Check Day by Day Subscription Details (Live Status)

Application Wise IPO Subscription (Retail): 10.74 times

CategorySubscription (times)








Glenmark Life Sciences IPO Funding Interest Rates Calculator

Glenmark Life Sciences IPO funding cost is derived based on the NII (HNI) over-subscription and interest rate considering the 7-day loan period. The table provides an estimated interest cost per share for rate of interest (ROI) ranging from 7 to 10% over a range of 10 different over-subscription intervals.

IPO Price₹720
NII IPO Quota₹233 Cr
NII Over-subscription
(Estimated in times)
NII IPO Collection
(Incremental in ₹ Cr)

Glenmark Life Sciences IPO HNI Cost for 7 days

NII IPO Collection (₹ Cr)0000000000
NII Over-subscription (times)0000000000
Interest Rate ↓↓ HNI Funding Cost (per share) ↓
IPO Funding Cost = IPO Price * NII Over-Subscription * (Interest Rate/100) * (7/365 days)


  • IPO Price is the upper price band in case of a book-built issue. 
  • NII Over-subscription is the number of times over-subscription in NII category. The table reflects data considering 80 time over-subscription as a starting point with the flexibility to change as desired.
  • ROI is the interest rate at which the loan gets granted.
  • 7-days is the loan funding period.

Note: The over-subscription intervals are derived based on the set incremental HNI IPO collection value. This value is currently set to 1000 which can be changed as desired based on the IPO issue size and price.

Glenmark Life Sciences IPO HNI Allotment Calculator

The Glenmark Life Sciences IPO Allotment Calculator for HNIs. It uses the number of shares applied, NII subscription, and lot size to calculate approximately how many equity shares an HNI will get. Note that the actual allotment quantity may be slightly different due to rejections in applications and share applied at different prices.

Shares in One Lot20
Shares Applied  Lots :
NII Over-subscription
(Estimated in times)
Expected Allotment

HNI IPO Allotment* = (Number of Lots Applied / NII Issue Over-subscription) * Shares in one lot

Note: If the numbers of lots applied are fewer than the oversubscription in the NII category, the allotment is done by lottery for one lot of shares.


You can apply for Glenmark Life Sciences IPO online through the Netbanking ASBA facility provided by your bank or through offline mode by filling and submitting the physical IPO application form.

Steps to apply online in Glenmark Life Sciences IPO as HNI

  1. Log into your Netbanking.
  2. Go to Investment/IPO section.
  3. Select the desired IPO.
  4. Enter the Investor category/Status as HNI.
  5. Fill in the bid details viz. Quantity/lots and price.
  6. Enter the personal information viz., Applicant name, PAN No., Email id, Bank account no., depository details.
  7. Apply.

Steps to apply offline in Glenmark Life Sciences IPO as HNI

  1. Procure the IPO application form from the nearest broker office, syndicate member office, or download the application form from NSE/BSE website.
  2. Fill in the below details in IPO Form:
    • Applicant Name
    • PAN Number
    • Bid Details - Quantity, Price
    • ASBA Bank Account Number
    • Tick the investor category as HNI.
  3. Submit the form to the nearest syndicate member/broker office.

Points to Note

  • An HNI cannot place a bid at the cut-off price.
  • An HNI cannot apply through UPI considering the UPI IPO Transaction limit of ₹2 lakhs.

You can invest in Glenmark Life Sciences IPO as HNI through ASBA Netbanking or offline mode.

You need to enter all the required details viz. the bid quantity, amount, depository details, bank account no., applicant name, PAN No. to apply for IPO online or offline. You need to ensure to select the investor category as HNI.

It is important to note that as an HNI, you cannot bid in IPO at the cut-off price.

You cannot apply in Glenmark Life Sciences IPO through the Zerodha IPO application(Console) in the HNI category as Zerodha offers a UPI-based IPO application that has a limit of a maximum of ₹2 lakh per transaction. 

You can apply using the ASBA facility offered by the banks to invest in the HNI category.

ICICI Direct offers a UPI-based IPO application with an upper limit of ₹2 lakh per transaction. Thus, an HNI cannot apply for Glenmark Life Sciences IPO through ICICI Direct.

To apply as an HNI in Glenmark Life Sciences IPO, you can apply online through Netbanking using the ASBA facility offered by banks or submit a physical IPO ASBA application form.

The three main factors that decide the feasibility to invest in Glenmark Life Sciences IPO using the IPO funding route.

  1. IPO Subscription Rate - This is one of the most critical factors that help decide whether an HNI should opt for a loan or not. The higher the subscription, the lower is the allotment. In the case of lesser allotment in IPO, selling that small chunk may not cover the entire funding cost and thus reduce the chances of earning profits.
  2. IPO Listing Price - If the IPO listing is expected at a good premium, taking an IPO loan should not be a burden as selling the shares on listing would earn handsome profit to cover the funding interest cost and the IPO price.
  3. IPO Funding Rate - Generally, IPO funding is available at around 7%-10%. The above IPO funding cost table shows an estimated cost that can help you arrive at the break-even point to assess the probability of earning profit based on the expected listing price and over-subscription.


1. Shahrushi  Aug 2, 2021 09:19
Dear Chittorgarh Team,
If possible can you please explain more about NII Incremental Collection (in CR) and what is its impact on GMP calculation.